Study of Microbiota in Bile From Patients With Common Bile Duct Stone During ERCP (NCT03490383) | Clinical Trial Compass
CompletedNot Applicable
Study of Microbiota in Bile From Patients With Common Bile Duct Stone During ERCP
China60 participantsStarted 2018-02-16
Plain-language summary
In this study, investigators will investigate the microbiota of bile in common bile duct stone participants. Three key questions are of concern. The first one is whether there is bacteriria in bile in participants without common bile duct stone. The second one is whether the microbiota of bile is similar with that of gut mucosa in common bile duct stone participants. The third one is whether the bacteria in bile of common bile participants with intact papillar is the same as that of participants underwent sphinctomy.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* CBD tumor or CBD calculi
Exclusion Criteria:
* contraindication for ERCP
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this study was looking at the bacteria found in bile from patients with common bile duct stones during ERCP, can you tell me if the findings from this research might change how my bile duct stone would be treated or which antibiotics might be used?
2This trial has already been completed — has my care team seen any published results about the types of bacteria found in bile during ERCP, and could those results be relevant to my specific situation?
3Since this was an observational study measuring microbiota rather than testing a new treatment, does it mean patients in this study received standard ERCP care, and is that the same approach you would recommend for me?
4Could the bacteria found in bile during ERCP procedures like this one affect my risk of infection after the procedure, and is that something we should plan around before I have one?
5Are there any ongoing follow-up studies based on this research that might be testing new treatments targeting bile duct bacteria, and would those be worth exploring as an option for me?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
microbiota in bile
Timeframe: intraoperative
Trial details
NCT IDNCT03490383
SponsorShanghai General Hospital, Shanghai Jiao Tong University School of Medicine